Erste Asset Management Gmb H Ab Cellera Biologics Inc. Transaction History
Erste Asset Management Gmb H
- $8.15 Trillion
- Q4 2024
A detailed history of Erste Asset Management Gmb H transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 62,000 shares of ABCL stock, worth $202,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,000
Previous 62,000
-0.0%
Holding current value
$202,740
Previous $162 Million
14.56%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
167Shares Held
120MCall Options Held
250KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$90 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$40 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$34.7 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$25.9 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$24 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $932M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...